Document Detail

Office management of chronic systolic heart failure.
MedLine Citation:
PMID:  19332224     Owner:  NLM     Status:  MEDLINE    
Evidence-based management of chronic systolic heart failure includes risk factor management, therapeutic lifestyle changes, and a polypharmaceutical regimen that prolongs survival, reduces or reverses progression of myocardial dysfunction, alleviates symptoms, and limits complications. Subspecialty consultation is warranted when symptoms progress despite standard therapy; interventions are needed for refractory coronary disease, an arrhythmia device is indicated, or surgical intervention or transplantation is considered.
Stephen A Geraci; Jessie M Spencer; Nancy D Stubbs
Related Documents :
12686014 - Acute myocardial infarction: antithrombotic therapy.
7738874 - Management of heart disease in the elderly in the plymouth health district.
17573694 - Loeffler endocarditis: what have we learned?
19000594 - Complications of arteriovenous hemodialysis access: recognition and management.
16442394 - Clinical and angiographic analysis with a cobalt alloy coronary stent (driver) in stabl...
7560754 - Adenosine activates cardiac sympathetic afferent fibers and potentiates the excitation ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The American journal of medicine     Volume:  122     ISSN:  1555-7162     ISO Abbreviation:  Am. J. Med.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-31     Completed Date:  2009-05-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  329-32     Citation Subset:  AIM; IM    
G V (Sonny) Montgomery Veterans Affairs Medical Center, Jackson, MS 39216, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Ambulatory Care / methods
Cardiology / methods
Cardiovascular Agents / adverse effects,  therapeutic use*
Chronic Disease
Evidence-Based Practice
Heart Failure, Systolic / drug therapy,  therapy*
Referral and Consultation
Risk Reduction Behavior
Reg. No./Substance:
0/Cardiovascular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Renal effects of anti-angiogenesis therapy: update for the internist.
Next Document:  Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD.